Risk of severe illness of COVID-19 patients with NAFLD and increased NAFLD fibrosis scores.

Renling YaoLi ZhuJian WangJiacheng LiuRuifei XueLeyang XueLonggen LiuChunyang LiHaiyan ZhaoJuan ChengSongping HuangYang LiXiang-An ZhaoChuanwu ZhuMing LiRui HuangChao Wu

Published in: Journal of clinical laboratory analysis (2021)

NAFLD patients with NFS-determined advanced liver fibrosis are at higher risk of severe COVID-19.

Keyphrases

liver fibrosis
sars cov
coronavirus disease
early onset
drug induced